For best experience please turn on javascript and use a modern browser!
You are using a browser that is no longer supported by Microsoft. Please upgrade your browser. The site may not present itself correctly if you continue browsing.
Bekijk de site in het Nederlands

Pancreatic cancer is one of the most lethal human diseases and currently treatment options are limited. Protease activated receptors (PARs), which are activated by blood coagulation factors, appear to play an important role in cancer progression. Kun Shi's research focuses on the role PARs play in the development of pancreatic cancer.

Event details of Protease activated receptors in pancreatic cancer
Date 5 June 2015
Time 14:00 -15:00
Location Agnietenkapel
Room Location

K.Shi: Blood Coagulation-(In)Dependent Protease Activated Receptor Signaling in Pancreatic Cancer.

Supervisor

Prof. D.J. Richel

Co-supervisor

Dr C.A. Spek

Agnietenkapel

Room Location

Oudezijds Voorburgwal 229 - 231
1012 EZ Amsterdam